Pharm
Docetaxel
search
Docetaxel
, Taxotere
See Also
Paclitaxel
Mitotic Inhibitor Chemotherapy
Chemotherapy
Indications
FDA Approved (often combined with other agents)
Breast Cancer
Gastric Cancer
Head and Neck Cancer (
Squamous Cell Carcinoma
)
Non-Small Cell Lung Cancer
Prostate Cancer
(metastatic,
Hormone
-refractory)
Off-Label
Melanoma
Non-Hodgkin's Lymphoma
Ovarian Cancer
Pancreatic Cancer
Sarcoma
(soft tissue)
Small Cell Lung Cancer
Urothelial Cancer
Mechanism
See
Mitotic Inhibitor Chemotherapy
Docetaxel is a semi-synthetic, second-generation
Taxane
Derived from extract of the European yew tree (Taxus baccata)
Docetaxel has antineoplastic activity (
Taxane
)
Binds and stabilizes tubulin
Inhibits microtubule disassembly
Results in
Cell Cycle
arrest in G2/M phase
Docetaxel inhibits proangiogenic factors (new vessel formation promotors)
Inhibits
Vascular Endothelial Growth Factor
(
VEGF
)
Docetaxel induces inflammatory response
Stimulates inflammatory mediators
Medications
Available in both IV and IV concentrate solutions: 20 mg to 200 mg vials
Dosing
See other references for disease specific dosing protocols
Adverse Effects
Edema
Fatigue
Hepatotoxicity
Hypersensitivity Reaction
(severe)
Subsequent reactions after an initial may grow in severity
Cross reacts with Paclitaxel
Hypersensitivity
Impaired future fertility
Intoxication
(
Alcohol
related)
Myelosuppression (
Bone Marrow
Suppression)
Neutropenia
(severe)
Peripheral Neuropathy
Less than
Paclitaxel
Paresthesia
s
Skin Changes
Extremity erythema
Nail pigmentation changes
Alopecia
(may be irreversible)
Safety
Avoid in
Lactation
Avoid in pregnancy (all trimesters)
Use reliable
Contraception
Monitoring
Complete Blood Count
Liver Function Test
s
Drug Interactions
CYP3A4
Inhibitors or substrates
Increases Docetaxel serum concentrations
Resources
Docetaxel Injection Solution (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0ec4bcc-93ea-4c41-a4b6-95ec19491807
Type your search phrase here